Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-19

FDA Approved: IPRATROPIUM BROMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical's supplemental application for ipratropium bromide, indicating updated labeling/indications for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

SUPPL AP for IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)